4.1 Review

Climate change, air pollution, and allergic respiratory diseases: an update

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ACI.0000000000000301

关键词

air pollution and respiratory diseases; airways hyperreactivity; climate change and asthma; climate change and respiratory allergy; thunderstorm asthma

向作者/读者索取更多资源

Purpose of reviewThe rising trend in prevalence of allergic respiratory disease and bronchial asthma, observed over the last decades, can be explained by changes occurring in the environment, with increasing presence of biologic, such as allergens, and chemical atmospheric trigger factors able to stimulate the sensitization and symptoms of these diseases.Recent findingsMany studies have shown changes in production, dispersion, and allergen content of pollen and spores because of climate change with an increasing effect of aeroallergens on allergic patients.SummaryOver the last 50 years, global earth's temperature has markedly risen likely because of growing emission of anthropogenic greenhouse gas concentrations. Major changes involving the atmosphere and the climate, including global warming induced by human activity, have a major impact on the biosphere and human environment.Urbanization and high levels of vehicle emissions are correlated to an increase in the frequency of pollen-induced respiratory allergy prevalent in people who live in urban areas compared with those who live in rural areas. Measures of mitigation need to be applied for reducing future impacts of climate change on our planet, but until global emissions continue to rise, adaptation to the impacts of future climate variability will also be required.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art

Alessandro Vatrella, Angelantonio Maglio, Corrado Pelaia, Girolamo Pelaia, Carolina Vitale

EXPERT OPINION ON PHARMACOTHERAPY (2020)

Review Allergy

The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens

Gennaro D'Amato, Herberto Jose Chong-Neto, Olga Patricia Monge Ortega, Carolina Vitale, Ignacio Ansotegui, Nelson Rosario, Tari Haathela, Carmen Galan, Ruby Pawankar, Margarita Murrieta, Lorenzo Cecchi, Christian Bergmann, Erminia Ridolo, German Ramon, Sandra Gonzalez Diaz, Maria D'Amato, Isabella Annesi-Maesano

ALLERGY (2020)

Article Pharmacology & Pharmacy

Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study

Valentina Giudice, Pasquale Pagliano, Alessandro Vatrella, Alfonso Masullo, Sergio Poto, Benedetto Maria Polverino, Renato Gammaldi, Angelantonio Maglio, Carmine Sellitto, Carolina Vitale, Bianca Serio, Bianca Cuffa, Anna Borrelli, Carmine Vecchione, Amelia Filippelli, Carmine Selleri

FRONTIERS IN PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation

Pasquale Ambrosino, Antonio Molino, Ilenia Calcaterra, Roberto Formisano, Silvia Stufano, Giorgio Alfredo Spedicato, Andrea Motta, Antimo Papa, Matteo Nicola Dario Di Minno, Mauro Maniscalco

Summary: This study found that endothelial function improved in convalescent COVID-19 patients after pulmonary rehabilitation, with a direct correlation between pulmonary function and endothelial health. Endothelial function testing may be useful for follow-up care in these patients.

BIOMEDICINES (2021)

Review Medicine, General & Internal

Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems

Valeria Visco, Carolina Vitale, Antonella Rispoli, Carmine Izzo, Nicola Virtuoso, Germano Junior Ferruzzi, Mario Santopietro, Americo Melfi, Maria Rosaria Rusciano, Angelantonio Maglio, Paola Di Pietro, Albino Carrizzo, Gennaro Galasso, Alessandro Vatrella, Carmine Vecchione, Michele Ciccarelli

Summary: While the acute effects of SARS-CoV-2 infection have been well-documented, this review highlights the need for a better understanding of the long-term effects. The review focuses on the potential involvement of the lungs, heart, and brain in post-viral syndromes and suggests strategies for managing post-COVID-19 symptoms. These symptoms include respiratory issues, cardiovascular events, neurological manifestations, and mental health issues.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β

Chiara Colarusso, Angelantonio Maglio, Michela Terlizzi, Carolina Vitale, Antonio Molino, Aldo Pinto, Alessandro Vatrella, Rosalinda Sorrentino

Summary: This study identified higher levels of CRP, C5b-9, and LDH in post-COVID-19 patients, which could predict the risk of pulmonary fibrosis. Moreover, increased levels of IL-1 alpha and TGF-beta, along with decreased levels of IFN-beta, were associated with an increased risk of lung fibrosis in these patients.

BIOMEDICINES (2021)

Article Biochemistry & Molecular Biology

Real-Life Effectiveness of Mepolizumab on Forced Expiratory Flow between 25% and 75% of Forced Vital Capacity in Patients with Severe Eosinophilic Asthma

Angelantonio Maglio, Carolina Vitale, Simona Pellegrino, Cecilia Calabrese, Maria D'Amato, Antonio Molino, Corrado Pelaia, Massimo Triggiani, Girolamo Pelaia, Cristiana Stellato, Alessandro Vatrella

Summary: The study found that mepolizumab significantly improves lung function in patients with severe eosinophilic asthma, particularly in enhancing small airway function, which is correlated with clinical benefits. Patients with high baseline peripheral blood eosinophil count and use of oral corticosteroids showed more significant improvements in small airway function after treatment.

BIOMEDICINES (2021)

Article Chemistry, Analytical

Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy)

Michele Ciccarelli, Fabrizio Merciai, Albino Carrizzo, Eduardo Sommella, Paola Di Pietro, Vicky Caponigro, Emanuela Salviati, Simona Musella, Veronica di Sarno, Mariarosaria Rusciano, Anna Laura Toni, Paola Iesu, Carmine Izzo, Gabriella Schettino, Valeria Conti, Eleonora Venturini, Carolina Vitale, Giuliana Scarpati, Domenico Bonadies, Antonella Rispoli, Benedetto Polverino, Sergio Poto, Pasquale Pagliano, Ornella Piazza, Danilo Licastro, Carmine Vecchione, Pietro Campiglia

Summary: This study utilized untargeted lipidomics to identify specific lipid profiles that can predict the severity and outcome of COVID-19 patients. These lipid profiles can be used for monitoring and targeted approaches during hospital admission.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)

Article Immunology

Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β

Chiara Colarusso, Michela Terlizzi, Angelantonio Maglio, Antonio Molino, Claudio Candia, Carolina Vitale, Philip M. Hansbro, Alessandro Vatrella, Aldo Pinto, Rosalinda Sorrentino

Summary: This study revealed that activation of the Absent in melanoma-2 (AIM2) inflammasome in COVID-19 long-haulers with lung fibrosis is associated with the release of IL-1 alpha, IFN-alpha, and TGF-beta. The release of IFN-alpha is caspase-1- and caspase-4-dependent, while the release of IL-1 alpha and TGF-beta is inflammasome independent. Higher expression of AIM2 in circulating CD14+ cells in PBMCs is correlated with lung fibrosis in COVID-19 patients.

FRONTIERS IN IMMUNOLOGY (2022)

Review Biochemistry & Molecular Biology

Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma

Alessandro Vatrella, Angelantonio Maglio, Corrado Pelaia, Luigi Ciampo, Giulia Pelaia, Carolina Vitale

Summary: This review focuses on severe asthma, its different subtypes, the role of eosinophilic inflammation, and the development of targeted anti-eosinophil therapies. It discusses the unique biology of eosinophils and their involvement in asthma, as well as current and prospective therapeutic strategies.

BIOMEDICINES (2022)

Article Biochemistry & Molecular Biology

Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study

Angelantonio Maglio, Carolina Vitale, Corrado Pelaia, Maria D'Amato, Luigi Ciampo, Eliana Sferra, Antonio Molino, Giulia Pelaia, Alessandro Vatrella

Summary: In this observational multicenter retrospective study, the effectiveness of mepolizumab and benralizumab in severe asthmatics treated for 12 months in a real-life setting was evaluated. The study found that 30.12% of patients on mepolizumab and 40% of patients on benralizumab achieved disease remission after 12 months. These results confirm the efficacy of anti-IL-5 biologic drugs in the treatment of severe eosinophilic asthma in a real-life setting.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, General & Internal

Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting

Carolina Vitale, Angelantonio Maglio, Corrado Pelaia, Maria D'Amato, Luigi Ciampo, Giulia Pelaia, Antonio Molino, Alessandro Vatrella

Summary: Patients with severe OCS-dependent asthma, who are a subgroup of asthma patients with severe disease, have a high risk of complications related to chronic OCS use. The introduction of benralizumab has provided a valid alternative to OCS and has shown effectiveness in reducing exacerbations, OCS intake, and improving symptom control and lung function. Data on long-term efficacy, however, is still limited and further research is needed.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Health Care Sciences & Services

Fractional Exhaled Nitric Oxide (FeNO) in Patients with Stable Chronic Obstructive Pulmonary Disease: Short-Term Variability and Potential Clinical Implications

Pasquale Ambrosino, Salvatore Fuschillo, Mariasofia Accardo, Marco Mosella, Antonio Molino, Giorgio Alfredo Spedicato, Andrea Motta, Mauro Maniscalco

Summary: This study assessed the short-term variability of FeNO in clinically stable COPD patients. The results showed individual variability of FeNO, apparently unrelated to eosinophil counts but influenced by body weight. Further research is needed to determine whether FeNO can be effectively used for personalized pharmacological and rehabilitation strategies in COPD patients.

JOURNAL OF PERSONALIZED MEDICINE (2022)

暂无数据